arthroplasty
发表于 2025-3-28 16:00:47
http://reply.papertrans.cn/19/1879/187816/187816_41.png
GROWL
发表于 2025-3-28 18:47:11
https://doi.org/10.1007/978-3-531-91170-0it might also be detected in muscle cells. In contrast to other markers of liver cell integrity like ASAT or Lactate Dehydrogenase, ALAT is highly specific for liver diseases. The sensitivity of elevated ALAT for hepatopathies is as high as 84% in large studies. The life span of a human liver cell i
Commission
发表于 2025-3-29 02:15:05
Konsens – der Grund der Legitimitäts of patients with liver disorders. All prognostic scores for liver diseases include bilirubin in their calculations, and some studies have shown that bilirubin is an independent biomarker of mortality risk. We know that a high total bilirubin level is an indicator of disease, but nowadays there is
Chagrin
发表于 2025-3-29 03:36:07
http://reply.papertrans.cn/19/1879/187816/187816_44.png
宽宏大量
发表于 2025-3-29 10:53:40
http://reply.papertrans.cn/19/1879/187816/187816_45.png
前奏曲
发表于 2025-3-29 13:55:26
http://reply.papertrans.cn/19/1879/187816/187816_46.png
下边深陷
发表于 2025-3-29 15:58:24
http://reply.papertrans.cn/19/1879/187816/187816_47.png
箴言
发表于 2025-3-29 20:03:59
Traditional Markers in Liver Disease physicians can be helped by specific markers used to diagnose and follow up liver diseases. In fact some of the enzymes and the end products of the metabolic pathway occurring in the liver are very sensitive for the abnormality occurred and, for this reason, may be considered as biochemical markers
情感脆弱
发表于 2025-3-30 00:12:14
Hepascore and Its Application to Liver Disease influences management. Histopathological staging of liver biopsy is considered the gold standard for assessment of liver fibrosis but is limited by its invasive nature, high cost, and sampling error. Hepascore is a serum model consisting of hyaluronic acid, bilirubin, alpha2-macroglobulin, gamma-gl
Itinerant
发表于 2025-3-30 04:33:17
Model for End-Stage Liver Disease (MELD) Score as a Biomarkertive. The model for end-stage liver disease (MELD) score was developed and is an accurate biomarker of 90-day mortality in patients with ESLD, essentially measuring how sick a patient is. The MELD score incorporates serum bilirubin, creatinine, and INR in a mathematical formula. Since 2002, the MELD